These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7830104)

  • 41. [Short-term and long-term surgical prophylaxis with pefloxacin].
    Rodolico A; Borruso L; Corrier M; Scalia E; Frazzetta M; Incandela S; Lauria B; Mazzarese S; Melloni D; Sanfilippo M
    G Chir; 1994; 15(1-2):45-50. PubMed ID: 8018476
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pefloxacin in the treatment of 24 suppurative infections.
    Desplaces N; Mamoudy P; Leonard P; Houdart R; Rouchy J; Kitzis M; Gutmann L
    Chemioterapia; 1987 Jun; 6(2 Suppl):394-5. PubMed ID: 3509457
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomized trial of pefloxacin plus klindamicin and cefoxitin in hepatobiliary and pancreatic surgery.
    Fried M; Peskova M
    Hepatogastroenterology; 1996; 43(7):306-8. PubMed ID: 8682484
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Postoperative infections in immunocompromised patients after oncological surgery.
    Ranchere JY; Gordiani B; Bachmann P
    Support Care Cancer; 1995 Nov; 3(6):409-13. PubMed ID: 8564345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of the effectiveness of the use of pefloxacin in combined radiation-thermal injury].
    Makarov GF; Budagov RS; Moiseeva LA; Boldueva NG
    Antibiot Khimioter; 1995 Aug; 40(8):36-9. PubMed ID: 8713436
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ready-to-use pefloxacin infusion for surgical prophylaxis.
    Bapat RD; Mohite JD; Bowalekar SK; Raghu CN
    Adv Ther; 1994; 11(5):269-75. PubMed ID: 10150267
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Infectious morbidity in gynecologic oncology.
    Graham JE
    J Reprod Med; 1990 Mar; 35(3 Suppl):348-52. PubMed ID: 2181122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pefloxacin in leprosy.
    Bharti R
    Indian J Lepr; 1994; 66(4):443-8. PubMed ID: 7714353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
    Kattan J; Droz JP; Ribrag V; Azab M; Boutan-Laroze A; Andremont A
    Eur J Cancer; 1992; 28A(4-5):867-70. PubMed ID: 1524911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monotherapy with pefloxacin in neutropenic febrile patients.
    Daniels-Bosman MS; Beun GD; Debrus-Palmans LL; Blijham GH
    Chemioterapia; 1987 Jun; 6(2 Suppl):410. PubMed ID: 3509459
    [No Abstract]   [Full Text] [Related]  

  • 51. A clinical trial of pefloxacin in prostatitis.
    Guibert J; Boutelier R; Guyot A
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():161-6. PubMed ID: 2258343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Can septicemia and ascitic fluid infections in cirrhotic patients be treated by the oral route alone?].
    Silvain C; Breux JP; Grollier G; Rouffineau J; Becq-Giraudon B; Beauchant M
    Gastroenterol Clin Biol; 1989 Apr; 13(4):335-9. PubMed ID: 2737389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serious, life-threatening infections: results with pefloxacin.
    Gargalianos P; Lelekis M; Lanaras L; Karakatsani E; Tsouroulas P; Kosmidis J
    J Chemother; 1989 Jul; 1(4 Suppl):672-3. PubMed ID: 16312586
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of respiratory tract infections with pefloxacin].
    Królikowski W; Głuszko P; Soja J; Prokop A; Wandzilak M; Klisiewicz-Pańszczyk T; Jurek I; Gruszka M; Sek S; Musiał J
    Pol Arch Med Wewn; 1991 Apr; 85(4):210-4. PubMed ID: 1881829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pefloxacin in the treatment of the bone and joint infections].
    Maiello A; Dassio G; Calvo MM; Gramoni A
    Minerva Med; 1999; 90(1-2):33-7. PubMed ID: 10388461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prevention using pefloxacin of infections in cancer patients with granulocytopenia].
    Leleux A; Snoeck R; Gerain J; Van der Auwera P; Daneau D; Meunier F
    Presse Med; 1989 Jan 7-14; 18(1):21-4. PubMed ID: 2521710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery.
    Gascón AR; Campo E; Olea E; Hernández RM; Calvo B; Errasti J; Pedraz JL
    Biopharm Drug Dispos; 2002 Oct; 23(7):293-300. PubMed ID: 12355580
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pefloxacin: clinical experience].
    Bertrand A; Janbon F; Jourdan J; Jonquet O; Santoni A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):596-9. PubMed ID: 3937133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical experience with pefloxacin in the therapy of typhoid fever.
    Cristiano P; Morelli G; Briante V; Iovene MR; Simioli F; Altucci P
    Infection; 1989; 17(2):86-7. PubMed ID: 2714862
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the therapeutic effect of pefloxacin in comparison with ampicillin and gentamicin in cirrhotic patients with spontaneous bacterial peritonitis.
    Rastegar LA; Umrani G; Dehbashi N; Malec F
    Hepatogastroenterology; 1998; 45(21):783-5. PubMed ID: 9684134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.